Assessing the impact of COVID-19 on registered interventional clinical trials.
Ontology highlight
ABSTRACT: The coronavirus disease 2019 (COVID-19) pandemic has led to a dramatic impact worldwide and presented unprecedented challenges for clinical and translational medicine. We assess the impact of COVID-19 on submitted and completed interventional clinical trials that have been registered on ClinicalTrials.gov. After classifying over 85% of the registered clinical trials by their source, we carefully model the number of submitted and completed trials before and after March 2020. Overall, we find minimal impact of COVID-19 on the number of submitted clinical trials, although a much more substantial impact is observed for completed clinical trials. We also show that clinical trials with a pharmaceutical sponsor were more successful at completing trials during the pandemic compared to the trials with academic/hospital/government sponsors.
SUBMITTER: Hawila N
PROVIDER: S-EPMC8212742 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA